2022
DOI: 10.1016/j.molstruc.2022.133024
|View full text |Cite
|
Sign up to set email alerts
|

A novel phospho triazine compound serving as an anticancer and antibacterial agent: An experimental-computational investigation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…A number of phosphoramide compounds and their organotin(IV) complexes have been structurally studied [ [6] , [7] , [8] ], where some of them have significant medicine applications such as antiviral, antitumor and anticancer activities [ [9] , [10] , [11] , [12] ]. Antibacterial and antimicrobial properties also have been found for some of phosphoramidate derivatives [ [13] , [14] , [15] , [16] ]. Moreover, some of these compounds are found to be the significant promising candidates to inhibit coronavirus [ [17] , [18] , [19] ]: some of the current not-optimal anti-coronavirus drugs, Remdesivir and Sofosbuvir, belong to the phosphoramides family [ 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…A number of phosphoramide compounds and their organotin(IV) complexes have been structurally studied [ [6] , [7] , [8] ], where some of them have significant medicine applications such as antiviral, antitumor and anticancer activities [ [9] , [10] , [11] , [12] ]. Antibacterial and antimicrobial properties also have been found for some of phosphoramidate derivatives [ [13] , [14] , [15] , [16] ]. Moreover, some of these compounds are found to be the significant promising candidates to inhibit coronavirus [ [17] , [18] , [19] ]: some of the current not-optimal anti-coronavirus drugs, Remdesivir and Sofosbuvir, belong to the phosphoramides family [ 20 , 21 ].…”
Section: Introductionmentioning
confidence: 99%
“…The dual-acting anticancer and antimicrobial chemotherapy agents have been published in many studies. 4,[43][44][45][46] Moreover, people with cancer may have a higher risk of infection due to changes in the immune system that controls their body's defenses. 47 Therefore, our potential derivatives have shown to be promising agents in the development of dual therapeutic effects.…”
Section: Anticancer Activitymentioning
confidence: 99%